Clinical Trial Update: A Study of Modified Stem Cells in Stable Ischemic Stroke [Phase 1, Phase 2]

View source ↗

Summary

Clinical trial update for modified stem cells in chronic ischemic stroke (Phase 1/Phase 2) completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke

Drugs mentioned

• Modified stem cells

Snippet

Sponsor: SanBio, Inc. | Conditions: Chronic Ischemic Stroke | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2023-02-03